Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Slow enrollment and therefore not possible to reach the estimated enrollment
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Acute respiratory distress syndrome (ARDS) is a devastating form of acute lung inflammation, that may be caused by a variety of insults with pulmonary and systemic infectious disease being the most common predisposing factor. Sepsis, on the other hand, represents the systemic inflammatory response to an invading pathogen, which may inflict damage upon the host through organ dysfunction. ARDS and sepsis are heterogenous clinical conditions that have a high mortality, and both diseases involve a complex interplay of different inflammatory mediators and cell types. It has been suggested that locally released inflammatory mediators pass from the lungs into the bloodstream following ARDS, triggering systemic inflammation. Conversely, it is possible that severe systemic inflammation may lead to ARDS by an influx of inflammatory mediators from the bloodstream to the lungs. However, the time course and the possible pathways for this transmission of disease have yet to be established.
Investigators hypothesize that:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Acute respiratory distress syndrome (ARDS) | |||
| Systemic inflammatory response syndrome (SIRS) | |||
| ARDS+SIRS |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Tumor necrosis factor alpha (TNF-a) bioactivity | Day one | |
| Tumor necrosis factor alpha (TNF-a) bioactivity | Day three | |
| Tumor necrosis factor alpha (TNF-a) bioactivity | Day seven | |
| Tumor necrosis factor alpha (TNF-a) bioactivity | Day fourteen |
| Measure | Description | Time Frame |
|---|---|---|
| Interleukin (IL)-6 | Day one | |
| Mannose binding lectin (MBL) | Day one | |
| Ficolin-1,2,3 |
Not provided
Inclusion Criteria:
General:
Specific:
-ARDS: acute (< 1 week) respiratory failure, characterized by hypoxemia (PaO2/FiO2 < 300 mmHg/40kPa), and bilateral infiltrates on x-ray or CT of thorax, that can not be explained by heart failure og overhydration.
OR
- SIRS (two of the following): Temperature > 38°C or < 36°C, heart rate > 90/min, respiratory frequency > 20 or PaCO2 < 4.2 kPa, leukocytosis (> 12x10^9/L) or leukopenia (< 4x10^9/L)
OR
ARDS + SIRS
Exclusion Criteria:
One lung ventilation; Tube size < 8.0 mm; INR > 1.5 or thrombocytes < 40x10^9/L; Intracranial hypertension; Malignant arrythmias
Not provided
Not provided
Not provided
Intensive care unit
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Intensive Care Unit, 4131, Rigshospitalet | Copenhagen Ø | 2100 | Denmark |
Not provided
| ID | Term |
|---|---|
| D012128 | Respiratory Distress Syndrome |
| D018746 | Systemic Inflammatory Response Syndrome |
| D018805 | Sepsis |
| ID | Term |
|---|---|
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D012120 | Respiration Disorders |
| D007249 | Inflammation |
Not provided
Not provided
Not provided
Not provided
Not provided
| Day one |
| D010335 |
| Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012769 | Shock |
| D007239 | Infections |